首页> 美国卫生研究院文献>Molecular Therapy Oncolytics >Programmable Nuclease-Based Integration into Novel Extragenic Genomic Safe Harbor Identified from Korean Population-Based CNV Analysis
【2h】

Programmable Nuclease-Based Integration into Novel Extragenic Genomic Safe Harbor Identified from Korean Population-Based CNV Analysis

机译:从韩国人口为基础的CNV分析确定的基于可编程核酸酶的整合入新型外源基因组安全港

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Here, we found two genomic safe harbor (GSH) candidates from chromosomes 3 and 8, based on large-scale population-based cohort data from 4,694 Koreans by CNV analysis. Furthermore, estimated genotype of these CNVRs was validated by quantitative real-time PCR, and epidemiological data examined no significant genetic association between diseases or traits and two CNVRs. After screening the GSH candidates by in silico approaches, we designed TALEN pairs to integrate EGFP expression cassette into human cell lines in order to confirm the functionality of GSH candidates in an in vitro setting. As a result, transgene insertion into one of the two loci using TALEN showed robust transgene expression comparable to that with an AAVS1 site without significantly perturbing neighboring genes. Changing the promoter or cell type did not noticeably disturb this trend. Thus, we could validate two CNVRs as a site for effective and safe transgene insertion in human cells.
机译:在这里,我们基于来自4694名韩国人的大规模人群队列数据,通过CNV分析,从3号和8号染色体中找到了两个基因组安全港(GSH)候选对象。此外,这些CNVR的估计基因型已通过实时定量PCR验证,并且流行病学数据未发现疾病或性状与两个CNVR之间存在显着的遗传关联。通过计算机方法筛选GSH候选物后,我们设计了TALEN对以将EGFP表达盒整合到人细胞系中,以在体外环境中确认GSH候选物的功能。结果,使用TALEN将转基因插入两个基因座之一显示出与AAVS1位点相当的强大转基因表达,而不会显着干扰邻近基因。改变启动子或细胞类型不会明显干扰这一趋势。因此,我们可以验证两个CNVRs作为在人类细胞中有效和安全转基因插入的位点。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号